Qiagen (QGEN) investor relations material

Opening remarks and agenda

• Roland Sackers chaired the meeting; Stephen H. Rusckowski, Jonathan Pratt, Kaspar Nuttigall and Christiana Williams attended in their stated roles.

• Record date was October 9, 2026; 206,496,521 shares had voting rights, with 137,321,285 represented, equal to 66% of issued share capital.

• Agenda items covered Thierry Bernard’s discharge, Jonathan Pratt’s appointment, and closure of the meeting.

Specific resolutions to be voted on

• Discharge of Thierry Bernard from liability for Managing Board duties from January 1 to his resignation on September 1, 2026, was adopted.

• Appointment of Jonathan Pratt as Managing Director, from the day after the meeting through the 2027 Annual General Meeting, was adopted.

Board and executive committee updates

• Thierry Bernard resigned from the Managing Board effective September 1, 2026; the meeting voted on his discharge for duties performed through that date.

• Jonathan Pratt was nominated as a new Managing Board member and appointed for a term ending at the 2027 Annual General Meeting.